Variant report
Variant | nsv539729 |
---|---|
Chromosome Location | chr8:115611957-115656200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:115648075..115653566-chr8:115653938..115656968,8 | MCF-7 | breast: | |
2 | chr8:115611607..115613247-chr8:115625084..115626919,2 | K562 | blood: | |
3 | chr8:115611607..115613247-chr8:115625084..115626919,2 | K562 | blood: | |
4 | chr8:115648075..115653566-chr8:115653938..115656968,8 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577825399 | chr8:115618040-115618041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183751940 | chr8:115618080-115618081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144477307 | chr8:115618103-115618104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573169804 | chr8:115618111-115618112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572437655 | chr8:115618175-115618176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542703091 | chr8:115618196-115618197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187609015 | chr8:115618199-115618200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576134928 | chr8:115618202-115618203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112457230 | chr8:115618261-115618262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541834757 | chr8:115618271-115618272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543571049 | chr8:115618293-115618294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6993330 | chr8:115618369-115618370 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs74354813 | chr8:115618374-115618375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191487452 | chr8:115618377-115618378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73358878 | chr8:115618389-115618390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547280308 | chr8:115619653-115619654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537242185 | chr8:115619662-115619663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111355662 | chr8:115619709-115619710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565928176 | chr8:115619738-115619739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367959404 | chr8:115619743-115619744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568790013 | chr8:115619801-115619802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200541617 | chr8:115619839-115619840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371885956 | chr8:115619862-115619863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554517386 | chr8:115619882-115619883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569746717 | chr8:115619924-115619925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572290574 | chr8:115619937-115619938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139965742 | chr8:115620017-115620018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536024299 | chr8:115620040-115620041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551230970 | chr8:115620081-115620082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541572572 | chr8:115620099-115620100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553305527 | chr8:115620170-115620171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187506183 | chr8:115620174-115620175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75135555 | chr8:115620230-115620231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76047310 | chr8:115620237-115620238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531375948 | chr8:115620257-115620258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185501792 | chr8:115620259-115620260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564949068 | chr8:115620266-115620267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374465804 | chr8:115620269-115620270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs56655686 | chr8:115620397-115620398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563200409 | chr8:115621691-115621692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530728782 | chr8:115621795-115621796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552514326 | chr8:115621817-115621818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563733755 | chr8:115621901-115621902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544548255 | chr8:115621983-115621984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184043075 | chr8:115641642-115641643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs16886186 | chr8:115641645-115641646 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs369518137 | chr8:115641666-115641667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544214494 | chr8:115641677-115641678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189393522 | chr8:115641724-115641725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533035704 | chr8:115641731-115641732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:115618000-115618400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr8:115619600-115620400 | Enhancers | Dnd41 | blood |
3 | chr8:115619800-115620000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr8:115619800-115620200 | Enhancers | Colon Smooth Muscle | Colon |
5 | chr8:115621600-115622000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr8:115641600-115642000 | Enhancers | Fetal Lung | lung |
7 | chr8:115649000-115649600 | Active TSS | H9 Cell Line | embryonic stem cell |
8 | chr8:115649000-115649600 | Active TSS | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr8:115649000-115649800 | Active TSS | HUES48 Cell Line | embryonic stem cell |
10 | chr8:115649000-115649800 | Active TSS | HUES64 Cell Line | embryonic stem cell |
11 | chr8:115649000-115650000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
12 | chr8:115649000-115650000 | Active TSS | HUES6 Cell Line | embryonic stem cell |
13 | chr8:115649200-115649600 | Active TSS | H1 Cell Line | embryonic stem cell |
14 | chr8:115649200-115649600 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
15 | chr8:115649200-115649600 | Active TSS | Hela-S3 | cervix |
16 | chr8:115649200-115649800 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
17 | chr8:115649200-115649800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
18 | chr8:115649200-115649800 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
19 | chr8:115649800-115650200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr8:115653600-115654000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
21 | chr8:115653600-115654600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |